Cargando…

Correlation of the Aryl Hydrocarbon Receptor with FSHR in Ovarian Cancer Patients

Expression of the aryl hydrocarbon receptor (AhR) has been described in various tumor entities from different organs. However, its role in ovarian cancer has not been thoroughly investigated. We aimed to elucidate the prognostic impact of AhR, its correlation with the follicle-stimulating hormone re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deuster, Eileen, Mayr, Doris, Hester, Anna, Kolben, Thomas, Zeder-Göß, Christine, Burges, Alexander, Mahner, Sven, Jeschke, Udo, Trillsch, Fabian, Czogalla, Bastian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628023/ https://www.ncbi.nlm.nih.gov/pubmed/31212758 http://dx.doi.org/10.3390/ijms20122862

Ejemplares similares

Correlation of NRF2 and progesterone receptor and its effects on ovarian cancer biology
por: Czogalla, Bastian, et al.
Publicado: (2019)

Cytoplasmic VDR expression as an independent risk factor for ovarian cancer
por: Czogalla, Bastian, et al.
Publicado: (2020)

The Platelet-Activating Factor Receptor’s Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by Rupatadine
por: Deuster, Eileen, et al.
Publicado: (2021)

Interaction of ERα and NRF2 Impacts Survival in Ovarian Cancer Patients
por: Czogalla, Bastian, et al.
Publicado: (2018)

M2 Macrophages Infiltrating Epithelial Ovarian Cancer Express MDR1: A Feature That May Account for the Poor Prognosis
por: Badmann, Susann, et al.
Publicado: (2020)

Nuclear Enolase-1/ MBP-1 expression and its association with the Wnt signaling in epithelial ovarian cancer
por: Czogalla, Bastian, et al.
Publicado: (2020)

Platelet-Activating Factor Acetylhydrolase Expression in BRCA1 Mutant Ovarian Cancer as a Protective Factor and Potential Negative Regulator of the Wnt Signaling Pathway
por: Liao, Yue, et al.
Publicado: (2021)

The role of resveratrol, Sirtuin1 and RXRα as prognostic markers in ovarian cancer
por: Chen, Fangfang, et al.
Publicado: (2021)

AKR1C1/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin
por: Badmann, Susann, et al.
Publicado: (2022)

Actin Beta-Like 2 as a New Mediator of Proliferation and Migration in Epithelial Ovarian Cancer
por: Topalov, Nicole Elisabeth, et al.
Publicado: (2021)

PLA2G7/PAF-AH as Potential Negative Regulator of the Wnt Signaling Pathway Mediates Protective Effects in BRCA1 Mutant Breast Cancer
por: Liao, Yue, et al.
Publicado: (2023)

Sirtuin1 expression and survival in endometrial and clear-cell uterine cancer
por: Beyer, Susanne, et al.
Publicado: (2020)

Expression pattern and prognostic potential of histamine receptors in epithelial ovarian cancer
por: Kraus, Fabian B. T., et al.
Publicado: (2022)

Nuclear receptor co-repressor NCOR2 and its relation to GPER with prognostic impact in ovarian cancer
por: Reichenbach, Juliane, et al.
Publicado: (2023)

H3K4me3 Is a Potential Mediator for Antiproliferative Effects of Calcitriol (1α,25(OH)2D3) in Ovarian Cancer Biology
por: Han, Nan, et al.
Publicado: (2020)

Subcellular Distribution of Thyroid Hormone Receptor Beta in Ovarian Cancer
por: Heublein, Sabine, et al.
Publicado: (2022)

Galectin-8 and -9 as prognostic factors for cervical cancer
por: Beyer, Susanne, et al.
Publicado: (2022)

Breast adipose tissue macrophages (BATMs) have a stronger correlation with breast cancer survival than breast tumor stroma macrophages (BTSMs)
por: Lin, Lili, et al.
Publicado: (2021)

The G-Protein-Coupled Estrogen Receptor (GPER) Regulates Trimethylation of Histone H3 at Lysine 4 and Represses Migration and Proliferation of Ovarian Cancer Cells In Vitro
por: Han, Nan, et al.
Publicado: (2021)

Cytoplasmic versus nuclear THR alpha expression determines survival of ovarian cancer patients
por: Ditsch, Nina, et al.
Publicado: (2020)

PD-L1 expression and survival in p16-negative and -positive squamous cell carcinomas of the vulva
por: Czogalla, Bastian, et al.
Publicado: (2020)

β-arrestin 2 Is a Prognostic Factor for Survival of Ovarian Cancer Patients Upregulating Cell Proliferation
por: Czogalla, Bastian, et al.
Publicado: (2020)

Protocol to optimize the biobanking of ovarian cancer organoids by accommodating patient-specific differences in stemness potential
por: Trillsch, Fabian, et al.
Publicado: (2023)

Vitamin D and VDR in Gynecological Cancers—A Systematic Review
por: Deuster, Eileen, et al.
Publicado: (2017)

Coexistence of adenomyosis uteri and endometrial cancer is associated with an improved prognosis compared with endometrial cancer only
por: Hertlein, Linda, et al.
Publicado: (2017)

Extracapsular Lymph Node Involvement in Ovarian Carcinoma
por: Heublein, Sabine, et al.
Publicado: (2019)

Potential of platinum-resensitization by Wnt signaling modulators as treatment approach for epithelial ovarian cancer
por: Kaltofen, Till, et al.
Publicado: (2020)

G Protein-Coupled Estrogen Receptor Correlates With Dkk2 Expression and Has Prognostic Impact in Ovarian Cancer Patients
por: Fraungruber, Patricia, et al.
Publicado: (2021)

High Galectin-7 and Low Galectin-8 Expression and the Combination of both are Negative Prognosticators for Breast Cancer Patients
por: Trebo, Anna, et al.
Publicado: (2020)

Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells
por: Kolben, Thomas, et al.
Publicado: (2022)

EP3 receptor antagonist L798,106 reduces proliferation and migration of SK-BR-3 breast cancer cells
por: Hester, Anna, et al.
Publicado: (2019)

Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer
por: Kolben, Thomas, et al.
Publicado: (2022)

Development and Validation of a Novel 11-Gene Prognostic Model for Serous Ovarian Carcinomas Based on Lipid Metabolism Expression Profile
por: Zheng, Mingjun, et al.
Publicado: (2020)

First Evidence for a Role of Siglec-8 in Breast Cancer
por: Trebo, Anna, et al.
Publicado: (2021)

Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer
por: Heublein, Sabine, et al.
Publicado: (2019)

Carbonic anhydrase XII as biomarker and therapeutic target in ovarian carcinomas
por: Hiepp, Lisa, et al.
Publicado: (2022)

High RIG-I and EFTUD2 expression predicts poor survival in endometrial cancer
por: Beyer, Susanne, et al.
Publicado: (2022)

The Prognostic Impact of the Aryl Hydrocarbon Receptor (AhR) in Primary Breast Cancer Depends on the Lymph Node Status
por: Jeschke, Udo, et al.
Publicado: (2019)

Her-2/neu expression is a negative prognosticator in ovarian cancer cases that do not express the follicle stimulating hormone receptor (FSHR)
por: Heublein, Sabine, et al.
Publicado: (2013)

Trends among patients with endometriosis over a 7-year period and the impact of the COVID-19 pandemic: experience from an academic high-level endometriosis centre in Germany
por: Keilmann, Lucia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5fq3dq0s8d8nd3ajjihqbgep0q